News Focus
News Focus
Post# of 257580
Next 10
Followers 843
Posts 122988
Boards Moderated 9
Alias Born 09/05/2002

Re: biotech_researcher post# 174945

Monday, 03/03/2014 3:43:43 PM

Monday, March 03, 2014 3:43:43 PM

Post# of 257580
ABBV/ENTA—The new info today is that PEARL-3 (treatment-naive GT1b) hit its secondary endpoints as well as the primary. (PEARL-3 top-line results were reported on 1/31/14: #msg-96618696.)

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now